LeMaitre Vascular

LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. The company is listed on NASDAQ.
Company Growth (employees)
Burlington, US
Size (employees)
397 (est)+18%
LeMaitre Vascular was founded in 1983 and is headquartered in Burlington, US

LeMaitre Vascular Office Locations

LeMaitre Vascular has offices in Burlington, Inzell, Chiyoda, Mississauga and in 4 other locations
Burlington, US (HQ)
63 Second Ave
North Melbourne, AU
36 Munster Terrace
San Giuliano Milanese, IT
86 Viale Leone Tolstoj
Madrid, ES
Plaza de España
Mississauga, CA
608 5915 Airport Rd
Inzell, DE
Otto-Volger-Str. 5 a/b 65843 Sulzbach/Ts
Show all (8)

LeMaitre Vascular Financials and Metrics

LeMaitre Vascular Financials

LeMaitre Vascular's revenue was reported to be $24.1 m in Q1, 2017

Revenue (Q1, 2017)

24.1 m

Gross profit (Q1, 2017)

17.4 m

Gross profit margin (Q1, 2017), %


Net income (Q1, 2017)

3.2 m

EBIT (Q1, 2017)

4.2 m

Market capitalization (20-Oct-2017)

779.2 m

Cash (31-Mar-2017)

25.8 m
LeMaitre Vascular's current market capitalization is $779.2 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016


64.5 m71.1 m78.4 m89.2 m

Revenue growth, %


Cost of goods sold

19.4 m22.7 m24.2 m26.2 m

Gross profit

45.1 m48.4 m54.2 m62.9 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017


18.2 m17.5 m18.9 m19.9 m19 m20.3 m22.4 m23.2 m24.1 m

Cost of goods sold

5.8 m5.5 m5.8 m6.8 m5.5 m5.9 m7 m6.2 m6.8 m

Gross profit

12.4 m12 m13.1 m13.1 m13.5 m14.4 m15.4 m17 m17.4 m

Gross profit Margin, %

USDFY, 2013FY, 2014FY, 2015FY, 2016


14.7 m18.7 m27.5 m24.3 m

Accounts Receivable

243.9 m


3.2 m2.4 m3.6 m2 m

Current Assets

41.7 m48.6 m58.2 m59 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017


23.5 m18.4 m17 m19.4 m23.6 m25.9 m29.3 m34.7 m25.8 m


15 m16.9 m16.5 m15.8 m15.9 m17.9 m17 m17.4 m

Current Assets

53 m49.4 m47.8 m50.3 m54 m59.7 m62.4 m68.2 m62.5 m


5.5 m7.2 m6.6 m6.6 m6.8 m7.4 m7.3 m7.5 m9.3 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

3.2 m3.9 m7.8 m10.6 m

Depreciation and Amortization

2.8 m3.3 m3.4 m3.6 m

Accounts Receivable

(1.2 m)(654 k)(1.9 m)(922 k)


(2.2 m)(2.7 m)608 k
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

1.1 m2 m1.4 m3.1 m5.2 m2.2 m4.8 m8 m3.2 m

Depreciation and Amortization

1.6 m2.4 m832 k1.7 m2.5 m881 k1.8 m2.7 m979 k

Accounts Receivable

(813 k)(194 k)(1.7 m)(1.8 m)(1.1 m)(825 k)(776 k)(68 k)(858 k)


(2.1 m)(2.5 m)(395 k)351 k(33 k)(392 k)264 k(216 k)(1.1 m)
USDY, 2017


71.2 k

Financial Leverage

1.2 x
Show all financial metrics

LeMaitre Vascular Market Value History

Traffic Overview of LeMaitre Vascular

LeMaitre Vascular Online and Social Media Presence

LeMaitre Vascular Company Life and Culture

You may also be interested in